Night-phase orexin receptor antagonism rescues AD by restoring sleep-dependent…

Mechanistic description

Timed OX1R/OX2R antagonism during the rest phase may consolidate sleep, improve glymphatic/interstitial clearance, and reduce amyloid or tau stress while avoiding daytime cognitive suppression. The therapeutic effect should depend on circadian timing.

Mechanism / pathway

HCRTR2
→
orexin signaling and glymphatic clearance
→
neurodegeneration

Evidence for (8)

PMID:41335394 Orexin-A and Circadian Disruption in Alzheimer's Disease
Glymphatic failure as a final common pathway to dementia
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.

PMID:34052813 2021 Front Neurol Neurosci
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.

PMID:34239348 2021 Int J Biol Sci
Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation.

PMID:36350059 2022 ACS Chem Neurosci
Quantitative Assessment of Hippocampal Tau Pathology in AD and PART.

PMID:32372343 2020 J Mol Neurosci
Roles of Microglia in AD Pathology.

PMID:36740796 2023 Curr Alzheimer Res
TDP-43 pathology is associated with increased tau burdens and seeding.

PMID:37777806 2023 Mol Neurodegener

Evidence against (2)

Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake transition and hemodynamic stability during propofol, dexmedetomidine, and remifentanil anesthesia.

PMID:40439868 2025 Pharmacol Rep

Evidence matrix

6 supporting 1 contradicting

86% supporting

Supporting

Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. PMID:34052813 · 2021 · Front Neurol Neurosci
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease. PMID:34239348 · 2021 · Int J Biol Sci
Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation. PMID:36350059 · 2022 · ACS Chem Neurosci
Quantitative Assessment of Hippocampal Tau Pathology in AD and PART. PMID:32372343 · 2020 · J Mol Neurosci
Roles of Microglia in AD Pathology. PMID:36740796 · 2023 · Curr Alzheimer Res
TDP-43 pathology is associated with increased tau burdens and seeding. PMID:37777806 · 2023 · Mol Neurodegener

Contradicting

Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake transition and hemodynamic stability during propofol, dexmedetomidine, and remifentanil anesthesia. PMID:40439868 · 2025 · Pharmacol Rep

Cite this hypothesis

Citation

etl-backfill (2026). Night-phase orexin receptor antagonism rescues AD by restoring sleep-dependent…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-665660604fa7

BibTeX

@misc{scidex_hypothesis_h6656606,
  title        = {Night-phase orexin receptor antagonism rescues AD by restoring sleep-dependent…},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-665660604fa7},
  note         = {SciDEX artifact hypothesis:h-665660604fa7}
}